LOM Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Buy
7,359
+125
+2% +$27.7K 0.46% 76
2025
Q4
$1.65M Sell
7,234
-133
-2% -$30.3K 0.48% 71
2025
Q3
$1.71M Sell
7,367
-105
-1% -$21.4K 0.52% 66
2025
Q2
$1.39M Buy
+7,472
New +$1.39M 0.47% 69

Other funds holding ABBV

LOM Asset Management's ABBV Position: Q1 2026 in Review

LOM Asset Management increased its AbbVie (ABBV) stake by 1.7% in Q1 2026, buying an estimated $27.7K and bringing the position to 7,359 shares worth $1.6M. The position accounts for 0.46% of the portfolio, ranked #76.

LOM Asset Management first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.71M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • LOM Asset Management held 7,359 shares of AbbVie worth $1.6M as of Q1 2026.
  • LOM Asset Management bought 125 AbbVie shares in Q1 2026, an estimated $27.7K.
  • AbbVie made up 0.46% of LOM Asset Management's portfolio in Q1 2026, its #76 holding.
  • LOM Asset Management first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • LOM Asset Management's AbbVie position peaked at $1.71M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LOM Asset Management's 13F filing for Q1 2026, filed 5 May 2026.